LABORATOIRES THEA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 93
- Registration Number
- NCT01568593
Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
Completed
- Conditions
- First Posted Date
- 2012-03-13
- Last Posted Date
- 2015-09-01
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 185
- Registration Number
- NCT01552174
- Locations
- 🇩🇪
Consultation office, Heidelberg, Germany
🇪🇸USIO Departamento de Oftalmologia Hospital Clínico San Carlos, Madrid, Spain
Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2012-03-07
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- Laboratoires Thea
- Registration Number
- NCT01546012
- Locations
- 🇩🇪
Augenklinik, Berlin, Germany
Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 30
- Registration Number
- NCT01494753
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 60
- Registration Number
- NCT01344083
- Locations
- 🇫🇷
Pierre Huguet, Clermont ferrand, France
Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2012-01-31
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 21
- Registration Number
- NCT01203540
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of
🇰🇷Seoul National University Boramae Medical Center, Seoul, Korea, Republic of
Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2010-12-06
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 20
- Registration Number
- NCT01190397
- Locations
- 🇬🇧
School of Optometry & Vision Sciences, Cardiff, United Kingdom
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
Phase 4
Completed
- Conditions
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2012-10-03
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 104
- Registration Number
- NCT01189474
- Locations
- 🇫🇷
76 Allée des Pins Tranquilles, Hossegord, France
🇫🇷Clinique du Cours Dillion, Toulouse, France
🇫🇷Hopital Dupuytren, Limoges, France
Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2010-07-02
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 16
- Registration Number
- NCT01156025
- Locations
- 🇫🇷
Medical Director, Clermont-Ferrand, France
Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 286
- Registration Number
- NCT01155999
© Copyright 2024. All Rights Reserved by MedPath